Completed PHASE3 INTERVENTIONAL 2-arm NCT03419676

Use of Hemopatch as a Sealant at the Pancreaticojejunostomy After Pancreatoduodenectomy

Use of Hemopatch as a Sealant at the Pancreaticojejunostomy After Pancreatoduodenectomy to Prevent Postoperative Pancreatic Fistula

Sponsor: Aragon Health Science Institute

Conditions Pancreatic Fistula

Interventions Hemopatch

Updated 7 times since 2018 Last updated: Feb 9, 2022 Started: May 1, 2018 Primary completion: Jun 30, 2020 Completion: Feb 10, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Pancreatic Fistula and is currently completed. Aragon Health Science Institute leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Mar 2022 — Jul 2024 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Jan 2021 — Mar 2022 [monthly]

Recruiting PHASE3
Feb 2020 — Jan 2021 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Jun 2018 — Feb 2020 [monthly]

Not Yet Recruiting PHASE3
Mar 2018 — Jun 2018 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aragon Health Science Institute
Hospital Miguel Servet

Data source: Hospital Miguel Servet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zaragoza, Spain